Foulks Gary N, Bron Anthony J
Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Ocul Surf. 2003 Jul;1(3):107-26. doi: 10.1016/s1542-0124(12)70139-8.
Although meibomian gland disease (MGD) is one of the most common disorders encountered in ophthalmic practice, there has been no descriptive system consistently accepted to clinically characterize the anatomical and correlative biochemical alterations that occur in this condition. The purpose of this review is to synthesize a clinical description of meibomian gland disease and to provide a scheme for diagnosis, classification, and quantification that will be of value in the clinical setting and in the conduct of clinical trials.
尽管睑板腺疾病(MGD)是眼科临床中最常见的病症之一,但目前尚无一个得到一致认可的描述系统,用于临床表征该病症中发生的解剖学及相关生化改变。本综述的目的是综合睑板腺疾病的临床描述,并提供一个诊断、分类和量化方案,这将在临床环境及临床试验中具有价值。